Skip to content

Safety and Efficacy of Carbone Dioxide Angiography for endovascular therapy in patients with chronic kidney disease: Prospective multicenter observational study

Safety and Efficacy of Carbone Dioxide Angiography for endovascular therapy in patients with chronic kidney disease: Prospective multicenter observational study - CO2 angiography registry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000008272
Enrollment
100
Registered
2012-06-28
Start date
2012-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with chronic kidney disease (eGFR&lt

Interventions

None listed

Sponsors

Kishiwada Tokushukai Hospital Hyogo Collage of Medicine
Lead Sponsor
Shin-Koga Hospital Tokeidai Memorial Hospital Miyazak Medical Association Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with chronic kidney disease (eGFR<60 mL/min/1.73m2) and symptomatic renal artery stenosis and/or symptomatic peripheral arterial disease ( Rutherford Classification Category 2-5)

Exclusion criteria

Exclusion criteria: Patients on Hemodialysis Patients with solitary below the knee artery disease

Design outcomes

Primary

MeasureTime frame
Worsening of renal function (serum Cr, eGFR)

Secondary

MeasureTime frame
1) Procedural success 2) Complications of procedure 3) Major adverse event (death, Myocardial infarction, end stage of renal dysfunction (renal death, renal replacement therapy),stroke, reintervenshon thrapy 4) Contrast induced nephropathy

Countries

Japan

Contacts

Public ContactMasahiko Fujihara

Kishiwada Tokushukai Hospital Cardiovascular Division

masahiko-fujihara@themis.ocn.ne.jp072-445-9915

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026